Note: Guardant Health's revenues are gauged from an analysis of company filings.
Guardant Health has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
August 9, 2017
Complete list of funding rounds and total amounts in the Company Report
Guardant Health's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Guardant Health Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Guardant Health is developing and marketing.
Guardant Health's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
GUARDANTOMNI Scientific research for medical purposes in the area of cancerous diseases; Structural and functional analysis of genomes; Healthcare services, namely, providing a database in the field of cancer related information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical testing for diagnostic or treatment purposes; Providing cancer screening services; Diagnostic kits for cancer screening
KNOW CANCER Medical and scientific research in the field of cancer treatment and diagnosis; Structural and functional analysis of genomes; providing a database of patient medical diagnoses and reassessment information for use in medical and scientific research in the field of cancer; consulting services in the field of medical reassessment of treatment of cancer and assessing genomic predisposition of developing cancer for medical and scientific research purposes
DIGITAL SEQUENCING Health care services, namely, providing a database in the field of cancer related information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical testing for diagnostic or treatment purposes
Patent applications show Guardant Health's intellectual property,
its current capabilities and future direction.
Guardant Health has applied for 11 patents since 2009.
Guardant Health's most recent patent was filed in August 2017 for Systems And Methods To Detect Rare Mutations And Copy Number Variation.The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
Complete list of patent applications
Determine whether Guardant Health grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Guardant Health is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Guardant Health vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Guardant Health, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Guardant Health.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Guardant Health and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.